CVS to Cover Lilly’s GLP-1 Medications, Expanding Access
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Total return indices show comprehensive performance by including dividends. Understanding them helps investors assess risk and compare strategies effectively.
27,899 articlesCVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Three Ethereum-native builders reveal the first confidential DeFi yield vault, allowing institutions to earn yields w...
A new Brookings-FED working paper casts doubt on ai’s $2.2 trillion deficit savings, warning that disruption and poli...
Bitcoin is still in a slowdown phase as traders unwind risk, with CryptoQuant data showing ongoing deleveraging but n...
Playnance’s G Coin launches into a week of rapid staking uptake and surging on-chain activity, turning the debut into...
Move, operator of Realtor.com, delivered a 10% year‑over‑year revenue gain in News Corp’s Q3 results. The broader com...
New York plaintiffs seek to claim ownership of nearly 3.8 million BTC from 39,069 dormant addresses, arguing the toke...
The EU’s MiCA deadline looms, challenging crypto platforms to win licenses or lose EU access. Binance’s Greece strate...
A retiree keeping 90% of a $1.7M portfolio in cash faces about $39,000 a year in lost growth, underscoring the long-t...
A wave of fresh users on Polymarket produced sizable winnings in a single session amid rising geopolitical tension, u...
A respected technical analyst outlines a Fibonacci-driven path that could push XRP to $27, igniting debate as regulat...
XRP trades around $1.40 with a market cap near $87B. Reaching $20 would require a multi-trillion dollar shift in dema...